We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
-12.34%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$30.7B
AUM Growth
-$977M
Cap. Flow
+$3.51B
Cap. Flow %
11.43%
Top 10 Hldgs %
8.45%
Holding
3,415
New
975
Increased
649
Reduced
497
Closed
726

Sector Composition

Rank Sector Weight
1 Industrials 11.74%
2 Technology 10.52%
3 Financials 10.44%
4 Healthcare 9.1%
5 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMFC icon
2176
New Mountain Finance
NMFC
$724M
$170K ﹤0.01%
+14,263
New +$184K
LEV
2177
DELISTED
The Lion Electric Company
LEV
$168K ﹤0.01%
+39,899
New +$234K
SCPL
2178
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$165K ﹤0.01%
+11,839
New +$158K
BRY
2179
DELISTED
Berry Corp
BRY
$163K ﹤0.01%
+21,340
New +$225K
EVGO icon
2180
EVgo
EVGO
$497M
$161K ﹤0.01%
+26,779
New +$255K
FCF icon
2181
First Commonwealth Financial
FCF
$2.18B
$161K ﹤0.01%
+11,992
New +$166K
KEEL
2182
Keel Infrastructure Corp
KEEL
$2.21B
$158K ﹤0.01%
+141,037
New +$320K
AZRE
2183
DELISTED
Azure Power Global Limited
AZRE
$158K ﹤0.01%
+13,860
New +$195K
ATER icon
2184
Aterian
ATER
$5.27M
$157K ﹤0.01%
+6,039
New +$267K
BBDC icon
2185
Barings BDC
BBDC
$966M
$151K ﹤0.01%
+16,258
New +$165K
ADSEW icon
2186
ADS-TEC Energy Warrant
ADSEW
$150K ﹤0.01%
250,000
ALLG
2187
DELISTED
Allego N.V.
ALLG
$150K ﹤0.01%
+29,497
New +$270K
VRN
2188
DELISTED
Veren
VRN
$149K ﹤0.01%
+20,953
New +$164K
GLAD icon
2189
Gladstone Capital
GLAD
$443M
$148K ﹤0.01%
+7,326
New +$166K
ACAD icon
2190
Acadia Pharmaceuticals
ACAD
$5.07B
$146K ﹤0.01%
+10,390
New +$194K
ATRA icon
2191
Atara Biotherapeutics
ATRA
$82.4M
$146K ﹤0.01%
+747
New +$122K
MONDW
2192
DELISTED
Mondee Holdings, Inc. Warrant
MONDW
$145K ﹤0.01%
500,000
+200,000
+67% +$89.9K
ARCO icon
2193
Arcos Dorados Holdings
ARCO
$1.67B
$143K ﹤0.01%
+21,230
New +$157K
AKTS
2194
DELISTED
Akoustis Technologies Inc
AKTS
$143K ﹤0.01%
+38,581
New +$171K
ICPT
2195
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$143K ﹤0.01%
+10,380
New +$166K
SIGA icon
2196
SIGA Technologies
SIGA
$207M
$142K ﹤0.01%
+12,265
New +$111K
XAGEW
2197
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$142K ﹤0.01%
371,250
OWLT.WS
2198
DELISTED
Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
OWLT.WS
$142K ﹤0.01%
500,000
DNMR
2199
DELISTED
Danimer Scientific, Inc.
DNMR
$140K ﹤0.01%
+766
New +$139K
GTHX
2200
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$140K ﹤0.01%
28,394
-781
-3% -$4.33K

Similar funds

Balyasny Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Balyasny Asset Management held 3,415 positions worth $30.7B, down 3.1% from $31.7B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Balyasny Asset Management deployed $3.51B of net new capital in Q2 2022, opening 975 new positions and adding to 649 existing holdings. Its largest new stake was RTX Corp: 2,351,649 shares worth $226M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was PNC Financial Services, an estimated $134M trimmed.

  • Balyasny Asset Management's largest Q2 2022 buy was RTX Corp: 2,351,649 shares worth $226M.
  • Balyasny Asset Management added most to iShares Russell 2000 ETF in Q2 2022, an estimated $245M increase.
  • Balyasny Asset Management's biggest Q2 2022 reduction was PNC Financial Services, cutting an estimated $134M.
  • Balyasny Asset Management fully exited Honeywell in Q2 2022, selling an estimated $179M.
  • Balyasny Asset Management's ten largest holdings make up 8.5% of its $30.7B portfolio in Q2 2022.
  • Balyasny Asset Management opened 975 new positions and closed 726 in Q2 2022.
  • Balyasny Asset Management's portfolio value fell 3.1% quarter-over-quarter to $30.7B.

Based on Balyasny Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.